AGP Executive Report
Last update: an hour agoFDA Recall Watch: New Jersey-based Breckenridge Pharmaceuticals is recalling duloxetine delayed-release capsules (Cymbalta) after tests found higher-than-permitted levels of a probable carcinogen; no illnesses reported, but the FDA classifies it as Class II. Drinking Water & Microplastics: AG Jeff Jackson praised EPA research on microplastics but urged mandatory monitoring in drinking water, warning risks could rise as concentrations increase. Weight-Loss Meds Planning: A medical explainer stresses GLP-1s work best with comprehensive, personalized care and ongoing monitoring—not as a standalone fix. Food Safety: A Listeria outbreak tied to Clover Hill Dairy ricotta has led to a multi-state cheese recall affecting New Jersey shoppers; consumers are told to check manufacturer permit numbers and discard listed products. Another Recall: Alfredo sauce sold in 41 states, including New Jersey, was upgraded to the highest-risk level over possible Salmonella contamination. Public Health Policy: Republican AGs and GOP lawmakers are urging EPA to classify mifepristone as a water contaminant, despite experts saying there’s no clear harm link. Local Health Access: Cooper University Health Care opened an LGBTQ+ clinic in South Jersey offering primary care, hormone care, and HIV prevention. Nutrition Warning: “Dirty soda” trends are drawing backlash for extreme sugar loads—often more like dessert than a beverage.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
